Regeneron Pharmaceuticals (REGN) Current Leases (2010 - 2026)
Regeneron Pharmaceuticals (REGN) recorded quarterly Current Leases of $720.0 million in Q1 2026, little changed quarter-over-quarter from $719.7 million in Q4 2021.
Regeneron Pharmaceuticals (REGN) Current Leases (2010 - 2026) Analysis & Trends
Regeneron Pharmaceuticals' Current Leases history runs 8 years deep, the most recent figure standing at $720.0 million for Q1 2026.
- In Q1 2026, Current Leases changed N/A year-over-year to $720.0 million; the TTM figure through Mar 2026 stood at $720.0 million (changed N/A YoY), while the FY2021 annual figure was $719.7 million, changed N/A from the prior year.
- Current Leases was $720.0 million for Q1 2026 at Regeneron Pharmaceuticals, roughly flat from $719.7 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $720.0 million in Q1 2026 to a low of $720.0 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 720.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 720.00 Mn |
| Dec 31, 2021 | 719.70 Mn |
| Sep 30, 2021 | 719.00 Mn |
| Jun 30, 2021 | 718.40 Mn |
| Mar 31, 2021 | 717.80 Mn |
| Dec 31, 2016 | 127.27 Mn |
| Sep 30, 2014 | 1.25 Mn |
| Jun 30, 2014 | 1.06 Mn |
| Mar 31, 2014 | 1.06 Mn |
| Dec 31, 2013 | 939,000.00 |
| Sep 30, 2013 | 794,000.00 |
| Jun 30, 2013 | 794,000.00 |
| Mar 31, 2013 | 1.47 Mn |
| Dec 31, 2012 | 1.37 Mn |
| Sep 30, 2012 | 1.28 Mn |
| Jun 30, 2012 | 1.18 Mn |
| Mar 31, 2012 | 1.09 Mn |
| Dec 31, 2011 | 1.01 Mn |
| Sep 30, 2011 | 920,000.00 |
| Jun 30, 2011 | 877,000.00 |